User profiles for Joanne Edwards
Joanne EdwardsProfessor of Translational Pathology, University of Glasgow Verified email at glasgow.ac.uk Cited by 16567 |
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion–resistant growth
…, CG Tepper, HJ Kung, AMH Brodie, J Edwards… - Cancer research, 2009 - AACR
The androgen receptor (AR) plays a key role in progression to incurable androgen ablation–resistant
prostate cancer (PCA). We have identified three novel AR splice variants lacking …
prostate cancer (PCA). We have identified three novel AR splice variants lacking …
Mannose impairs tumour growth and enhances chemotherapy
…, A Hoyle, D Millan, IA McNeish, OJ Sansom, J Edwards… - Nature, 2018 - nature.com
It is now well established that tumours undergo changes in cellular metabolism 1. As this
can reveal tumour cell vulnerabilities and because many tumours exhibit enhanced glucose …
can reveal tumour cell vulnerabilities and because many tumours exhibit enhanced glucose …
[HTML][HTML] The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being
known for decades (Warburg effect), the molecular mechanisms regulating this switch …
known for decades (Warburg effect), the molecular mechanisms regulating this switch …
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer
Continued androgen receptor (AR) signaling is an established mechanism underlying
castration-resistant prostate cancer (CRPC), and suppression of androgen receptor signaling …
castration-resistant prostate cancer (CRPC), and suppression of androgen receptor signaling …
Gene amplifications associated with the development of hormone-resistant prostate cancer
Purpose: Hormone resistance remains a significant clinical problem in prostate cancer with
few therapeutic options. Research into mechanisms of hormone resistance is essential. …
few therapeutic options. Research into mechanisms of hormone resistance is essential. …
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Introduction Breast cancer remains a significant scientific, clinical and societal challenge.
This gap analysis has reviewed and critically assessed enduring issues and new challenges …
This gap analysis has reviewed and critically assessed enduring issues and new challenges …
Observer variation in immunohistochemical analysis of protein expression, time for a change?
Aim : Immunohistochemical analysis of protein expression is central to most clinical translational
studies and defines patient treatment or selection criteria for novel drugs. Interobserver …
studies and defines patient treatment or selection criteria for novel drugs. Interobserver …
NF-κB pathways in the development and progression of colorectal cancer
Nuclear factor-κB (NF-κB) has been widely implicated in the development and progression of
cancer. In colorectal cancer (CRC), NF-κB has a key role in cancer-related processes such …
cancer. In colorectal cancer (CRC), NF-κB has a key role in cancer-related processes such …
[HTML][HTML] High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated …
Various studies in cell lines have previously demonstrated that sphingosine kinase 1 (SK1)
and extracellular signal-regulated kinase 1/2 (ERK-1/2) interact in an estrogen receptor (ER)-…
and extracellular signal-regulated kinase 1/2 (ERK-1/2) interact in an estrogen receptor (ER)-…
Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer
…, R Mukherjee, JMS Bartlett, J Edwards - British journal of …, 2007 - nature.com
The main cause of prostate cancer-related mortality is the development of hormone-refractory
disease. Circulating serum levels of IL-6 are raised in hormone-refractory prostate cancer …
disease. Circulating serum levels of IL-6 are raised in hormone-refractory prostate cancer …